Scientists assessed the immunogenicity of six recently published novel influenza-derived peptides identified by mass-spectrometry and predicted to bind to the prevalent HLA-B*18:01 molecule.
[Clinical & Translational Immunology]
Home Newsletters Immunology of Infectious Disease News Characterization of Novel Influenza-Derived HLA-B*18:01-Restricted Epitopes
